Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 16, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-04
DOI
10.3389/fnins.2022.939855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia Polarization From M1 to M2 in Neurodegenerative Diseases
- (2022) Shenrui Guo et al. Frontiers in Aging Neuroscience
- An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor
- (2022) Annu et al. Frontiers in Bioengineering and Biotechnology
- The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease
- (2022) Jiuhong Zhao et al. Colloid and Interface Science Communications
- Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease
- (2021) Livia La Barbera et al. PROGRESS IN NEUROBIOLOGY
- Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
- (2021) Weisen Zhang et al. Advanced Science
- Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents
- (2021) Zhi Du et al. ACCOUNTS OF CHEMICAL RESEARCH
- Targeting autophagy as a therapeutic strategy to prevent dopamine neuron loss in early stages of Alzheimer disease
- (2021) Annalisa Nobili et al. Autophagy
- Role of natural plant products against Alzheimer’s disease
- (2021) Himanshi Varshney et al. CNS & Neurological Disorders-Drug Targets
- Nano-encapsulation of hydroxytyrosol into formulated nanogels improves therapeutic effects against hepatic steatosis: An in vitro study
- (2021) Emanuele Mauri et al. Materials Science & Engineering C-Materials for Biological Applications
- Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
- (2021) Amanda Cano et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
- (2021) A. Duro-Castano et al. Science Advances
- Carbon Dots: A Future Blood–Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier
- (2021) Wei Zhang et al. International Journal of Nanomedicine
- Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment
- (2021) Laura Serra et al. JOURNAL OF ALZHEIMERS DISEASE
- A review on advances of treatment modalities for Alzheimer's disease
- (2021) Ewen Se Thoe et al. LIFE SCIENCES
- Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations
- (2021) Syed Nasir Abbas Bukhari Current Drug Delivery
- Synthesis and Characterization of a “Clickable” PBR28 TSPO-Selective Ligand Derivative Suitable for the Functionalization of Biodegradable Polymer Nanoparticles
- (2021) Renato Auriemma et al. Nanomaterials
- Tuning the Elasticity of Polymersomes for Brain Tumor Targeting
- (2021) Meng Zheng et al. Advanced Science
- Coassembled Chitosan–Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer’s β-Amyloid
- (2021) Wenjuan Wang et al. ACS Applied Materials & Interfaces
- Natural product-based nanomedicine: Recent advances and issues for the treatment of Alzheimer's disease
- (2021) Choy Ker Woon et al. Current Neuropharmacology
- Highly stable branched cationic polymer-functionalized black phosphorus electrochemical sensor for fast and direct ultratrace detection of copper ion
- (2021) Yuan Li et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
- (2021) Arianna Sala et al. Alzheimers Research & Therapy
- Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model
- (2021) Elena Spoleti et al. EXPERIMENTAL NEUROLOGY
- Gold Nanoparticles in Conjunction with Nucleic Acids as a Modern Molecular System for Cellular Delivery
- (2020) Anna Graczyk et al. MOLECULES
- Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy
- (2020) Hossein Derakhshankhah et al. Nanomedicine-Nanotechnology Biology and Medicine
- Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
- (2020) William M. Pardridge Frontiers in Aging Neuroscience
- In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer’s Disease
- (2020) Leonardo Iaccarino et al. JOURNAL OF ALZHEIMERS DISEASE
- PND36 HEALTHCARE COSTS ASSOCIATED WITH ALZHEIMER’S DISEASE IN THE US AND EU-5: A SYSTEMATIC LITERATURE REVIEW
- (2020) K. Prabhune et al. VALUE IN HEALTH
- Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases
- (2020) Ajay Kumar et al. Frontiers in Neuroscience
- Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
- (2020) Sudip Mukherjee et al. ADVANCED FUNCTIONAL MATERIALS
- Anti-Amyloid-β Protein agents for the treatment of Alzheimer’s Disease: An update on emerging drugs
- (2020) Madia Lozupone et al. EXPERT OPINION ON EMERGING DRUGS
- Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection
- (2020) Yanyue Wu et al. Nanomaterials
- Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
- (2020) Amy F. T. Arnsten et al. Alzheimers & Dementia
- A Survey of Strain‐Promoted Azide‐Alkyne Cycloaddition in Polymer Chemistry
- (2020) Alex Adronov et al. CHEMISTRY-A EUROPEAN JOURNAL
- Tuning small molecule release from polymer micelles: Varying H2S release through cross linking in the micelle core
- (2020) Ryan J. Carrazzone et al. EUROPEAN POLYMER JOURNAL
- Chitosan-decorated nanoparticles for drug delivery
- (2020) María Luisa Del Prado-Audelo et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
- (2020) Sara Silva et al. Nanomaterials
- Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview
- (2020) Muhammad Bilal et al. NanoImpact
- Photomodulating Carbon Dots for Spatiotemporal Suppression of Alzheimer’s β-Amyloid Aggregation
- (2020) You Jung Chung et al. ACS Nano
- Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers
- (2020) Divya Gopalan et al. NANOTECHNOLOGY
- Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
- (2020) Fangda Leng et al. Nature Reviews Neurology
- Characterization of tau binding by gosuranemab
- (2020) Richelle Sopko et al. NEUROBIOLOGY OF DISEASE
- A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer’s Disease Therapy
- (2020) Ying Kuang et al. Frontiers in Bioengineering and Biotechnology
- Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
- (2019) Ka Wong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transferrin Receptor-Mediated Uptake at the Blood–Brain Barrier Is Not Impaired by Alzheimer’s Disease Neuropathology
- (2019) Philippe Bourassa et al. MOLECULAR PHARMACEUTICS
- Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
- (2019) Victor M. Pulgar Frontiers in Neuroscience
- Size-Dependent Effect of Silver Nanoparticles on the Tumor Necrosis Factor α-Induced DNA Damage Response
- (2019) Alaa Fehaid et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ventral tegmental area disruption in Alzheimer’s disease
- (2019) Marco Bozzali et al. Aging-US
- Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease
- (2019) Fikret Türkan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses
- (2019) Xu-Qiao Chen et al. Frontiers in Neuroscience
- Ligand density on nanoparticles: A parameter with critical impact on nanomedicine
- (2019) Alaaldin M. Alkilany et al. ADVANCED DRUG DELIVERY REVIEWS
- Alzheimer’s disease: future drug development and the blood-brain barrier
- (2019) William M. Pardridge EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
- (2019) Jyoti Gupta et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis
- (2019) Rana Abdul Razzak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody
- (2019) Phillip W. Janowicz et al. Scientific Reports
- Surface-Modified G4 PAMAM Dendrimers Cross the Blood–Brain Barrier Following Multiple Tail-Vein Injections in C57BL/6J Mice
- (2019) Bhairavi Srinageshwar et al. ACS Chemical Neuroscience
- Safety and efficacy of focused ultrasound induced blood-brain barrier opening, an integrative review of animal and human studies
- (2019) Ying Meng et al. JOURNAL OF CONTROLLED RELEASE
- Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
- (2019) Elizabeth M. Rhea et al. Frontiers in Neuroscience
- Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients
- (2019) Negin Mozafari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Conjugated Polymer-Quantum Dot Hybrid Materials for Pathogen Discrimination and Disinfection
- (2019) Haitao Yuan et al. ACS Applied Materials & Interfaces
- Selective Modulation of A1 Astrocytes by Drug-Loaded Nano-Structured Gel in Spinal Cord Injury
- (2019) Irma Vismara et al. ACS Nano
- Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
- (2019) Divya Gopalan et al. JOURNAL OF CONTROLLED RELEASE
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- (2019) Delia Belelli et al. Neurobiology of Stress
- Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications
- (2018) Hyemin Kim et al. ADVANCED MATERIALS
- Gold laced bio-macromolecules for theranostic application
- (2018) Pranjali Yadav et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Volume and Connectivity of the Ventral Tegmental Area are Linked to Neurocognitive Signatures of Alzheimer’s Disease in Humans
- (2018) Matteo De Marco et al. JOURNAL OF ALZHEIMERS DISEASE
- Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting
- (2018) Lucía Martínez-Jothar et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
- (2018) Dario Carradori et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease
- (2018) Alberto Cordella et al. NEUROBIOLOGY OF DISEASE
- Near-Infrared Switchable Fullerene-Based Synergy Therapy for Alzheimer's Disease
- (2018) Zhi Du et al. Small
- Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease
- (2018) Erik S. Musiek et al. JAMA Neurology
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective
- (2018) Quanguo He et al. Cells
- Single-chain polymer nanoparticles in controlled drug delivery and targeted imaging
- (2018) A. Pia P. Kröger et al. JOURNAL OF CONTROLLED RELEASE
- Application of nanodiagnostics and nanotherapy to CNS diseases
- (2018) Weiyuan Zhang et al. Nanomedicine
- The amyloid hypothesis on trial
- (2018) Simon Makin NATURE
- A molecular atlas of cell types and zonation in the brain vasculature
- (2018) Michael Vanlandewijck et al. NATURE
- In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease
- (2018) Laura Serra et al. NEUROBIOLOGY OF AGING
- Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity
- (2018) Zhiqiang Jiang et al. Scientific Reports
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Ligand Density and Linker Length are Critical Factors for Multivalent Nanoparticle–Receptor Interactions
- (2018) Kathrin Abstiens et al. ACS Applied Materials & Interfaces
- Adsorption of proteins on gold nanoparticles: One or more layers?
- (2018) Dmitriy V. Sotnikov et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
- (2018) Kiran reddy Kanubaddi et al. International Journal of Nanomedicine
- Liposome delivery systems for the treatment of Alzheimer’s disease
- (2018) Callum Ross et al. International Journal of Nanomedicine
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- Blood-Brain Barrier: From Physiology to Disease and Back
- (2018) Melanie D. Sweeney et al. PHYSIOLOGICAL REVIEWS
- Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities
- (2018) Muhammad Ovais et al. Frontiers in Aging Neuroscience
- Editorial: Advances and Challenges in Nanomedicine
- (2018) Susan Hua et al. Frontiers in Pharmacology
- The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics
- (2018) Cristina de la Torre et al. Pharmaceutics
- Novel functionalization strategies to improve drug delivery from polymers
- (2017) Emanuele Mauri et al. Expert Opinion on Drug Delivery
- Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders
- (2017) Beihui Liu et al. GLIA
- Synthesis of nano- and microstructures from proanthocyanidins, tannic acid and epigallocatechin-3-O-gallate for active delivery
- (2017) Elisavet D. Bartzoka et al. GREEN CHEMISTRY
- Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
- (2017) Prakash Bhatt et al. International Journal of Nanomedicine
- Anti-Alzheimer's potential of berberine using surface decorated multi-walled carbon nanotubes: A preclinical evidence
- (2017) Shikha Lohan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
- (2017) Ming Ming Wen et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway
- (2017) Jingkao Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Solanezumab: too late in mild Alzheimer's disease?
- (2017) The Lancet Neurology LANCET NEUROLOGY
- Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer's type
- (2017) Alexandre Pastoris Muller et al. Materials Science & Engineering C-Materials for Biological Applications
- Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ 1-42 -induced neuroinflammation and neurodegeneration via the NF- K B /JNK/GSK3β signaling pathway
- (2017) Min Ju Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- Tau-based therapies in neurodegeneration: opportunities and challenges
- (2017) Chuanzhou Li et al. NATURE REVIEWS DRUG DISCOVERY
- The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
- (2017) Tamar Amit et al. NEUROPHARMACOLOGY
- Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
- (2017) Stefania Forner et al. TRENDS IN NEUROSCIENCES
- Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease
- (2017) Annalisa Nobili et al. Nature Communications
- Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
- (2017) Y. Anraku et al. Nature Communications
- How to make nanobiosensors: surface modification and characterisation of nanomaterials for biosensing applications
- (2017) Meral Yüce et al. RSC Advances
- Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
- (2017) Arijita Deb et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
- (2017) Muhammad Ayaz et al. Frontiers in Aging Neuroscience
- Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us
- (2017) Hélène E. Hirbec et al. Frontiers in Aging Neuroscience
- Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis
- (2017) David Azria et al. Journal of Materials Chemistry B
- Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1–42-induced oxidative stress
- (2017) Faiz Ul Amin et al. JOURNAL OF NANOBIOTECHNOLOGY
- Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE)
- (2017) Richard J. Kryscio et al. JAMA Neurology
- Anti-Alzheimer’s Studies on β-Sitosterol Isolated from Polygonum hydropiper L.
- (2017) Muhammad Ayaz et al. Frontiers in Pharmacology
- Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking
- (2017) Mumtaz Ali et al. Frontiers in Pharmacology
- Efficient Inhibition of Protein Aggregation, Disintegration of Aggregates, and Lowering of Cytotoxicity by Green Tea Polyphenol-Based Self-Assembled Polymer Nanoparticles
- (2016) Koushik Debnath et al. ACS Applied Materials & Interfaces
- Polysaccharide-based nanoparticles for theranostic nanomedicine
- (2016) M. Swierczewska et al. ADVANCED DRUG DELIVERY REVIEWS
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment
- (2016) Zahinoor Ismail et al. Alzheimers & Dementia
- Preparation of Inert Polystyrene Latex Particles as MicroRNA Delivery Vectors by Surfactant-Free RAFT Emulsion Polymerization
- (2016) Cheuk Ka Poon et al. BIOMACROMOLECULES
- Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease
- (2016) Pasquale Picone et al. BIOMATERIALS
- Chemical composition, antioxidant and anticholinesterase potentials of essential oil of Rumex hastatus D. Don collected from the North West of Pakistan
- (2016) Sajjad Ahmad et al. BMC Complementary and Alternative Medicine
- Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease
- (2016) Dongdong Sun et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review
- (2016) Gilberto Alves et al. Current Alzheimer Research
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Effect of PLGA NP size on efficiency to target traumatic brain injury
- (2016) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process
- (2016) Somayeh Mirsadeghi et al. Materials Science & Engineering C-Materials for Biological Applications
- Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells
- (2016) Ghislain Djiokeng Paka et al. MOLECULAR PHARMACEUTICS
- Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles
- (2016) Ulrike Wais et al. Nanoscale
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Pericytes of the neurovascular unit: key functions and signaling pathways
- (2016) Melanie D Sweeney et al. NATURE NEUROSCIENCE
- Therapeutic strategies for Alzheimer's disease in clinical trials
- (2016) Justyna Godyń et al. Pharmacological Reports
- Sialic Acid Mimetics to Target the Sialic Acid–Siglec Axis
- (2016) Christian Büll et al. TRENDS IN BIOCHEMICAL SCIENCES
- Drug development in Alzheimer’s disease: the path to 2025
- (2016) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
- (2016) Francesco Panza et al. Biomed Research International
- Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
- (2016) Mark Ultsch et al. Scientific Reports
- Analysis of the brain mural cell transcriptome
- (2016) Liqun He et al. Scientific Reports
- Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
- (2015) Meghna Talekar et al. AAPS Journal
- Elasticity of Nanoparticles Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting
- (2015) Aaron C. Anselmo et al. ACS Nano
- Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease
- (2015) Tiantian Yin et al. Acta Biomaterialia
- Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
- (2015) Yvonne Bouter et al. ACTA NEUROPATHOLOGICA
- Cationic Albumin-Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration
- (2015) Golnaz Kamalinia et al. Chemical Biology & Drug Design
- Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease
- (2015) Keshav Anand et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Resveratrol nanoformulations: Challenges and opportunities
- (2015) Natalie Summerlin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Brain barriers: Crosstalk between complex tight junctions and adherens junctions
- (2015) Silvia Tietz et al. JOURNAL OF CELL BIOLOGY
- Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection
- (2015) Muge Yemisci et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Complexity and simplification in the development of nanomedicines
- (2015) Matthias Barz Nanomedicine
- GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
- (2015) Ethan A Winkler et al. NATURE NEUROSCIENCE
- Solanezumab—prospects for meaningful interventions in AD?
- (2015) Sam Gandy et al. Nature Reviews Neurology
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Polymeric multifunctional nanomaterials for theranostics
- (2015) Haisheng Peng et al. Journal of Materials Chemistry B
- The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease
- (2015) Paola Flores-RodrÃguez et al. Frontiers in Neuroscience
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
- (2014) Muna Aryal et al. ADVANCED DRUG DELIVERY REVIEWS
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
- (2014) Khalid Iqbal et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting microglia for the treatment of Alzheimer’s disease
- (2014) Patrick L McGeer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Toxicity of polymeric nanoparticles in vivo and in vitro
- (2014) Nadine Voigt et al. JOURNAL OF NANOPARTICLE RESEARCH
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functionalized polystyrene nanoparticles as a platform for studying bio–nano interactions
- (2014) Cornelia Loos et al. Beilstein Journal of Nanotechnology
- Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
- (2014) João Conde et al. Frontiers in Chemistry
- Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
- (2013) Houshang Amiri et al. ACS Chemical Neuroscience
- Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
- (2013) Andrew D. Watt et al. ACTA NEUROPATHOLOGICA
- B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
- (2013) Zhongyang Liu et al. BIOCONJUGATE CHEMISTRY
- Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
- (2013) Zhongyang Liu et al. BIOMATERIALS
- Cationic core–shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy
- (2013) Lili Qian et al. BIOMATERIALS
- Amino-functionalized nanoparticles as inhibitors of mTOR and inducers of cell cycle arrest in leukemia cells
- (2013) Cornelia Loos et al. BIOMATERIALS
- Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
- (2013) Aaron H. Burstein et al. CLINICAL NEUROPHARMACOLOGY
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- Preparation, characterization,in vivobiodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting
- (2013) Shadab Md et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound
- (2013) Jessica F. Jordão et al. EXPERIMENTAL NEUROLOGY
- Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
- (2013) Michelle A Erickson et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Alkyne-Azide “Click” Chemistry in Designing Nanocarriers for Applications in Biology
- (2013) Pramod Avti et al. MOLECULES
- Schiff Bases: A Short Survey on an Evergreen Chemistry Tool
- (2013) Wenling Qin et al. MOLECULES
- Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
- (2013) Malka Shilo et al. Nanoscale
- Development, maintenance and disruption of the blood-brain barrier
- (2013) Birgit Obermeier et al. NATURE MEDICINE
- Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms
- (2013) Daniela Giuliani et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Resveratrol Inhibits β-Amyloid-Induced Neuronal Apoptosis through Regulation of SIRT1-ROCK1 Signaling Pathway
- (2013) Xiaowen Feng et al. PLoS One
- Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro
- (2013) Radka Gromnicova et al. PLoS One
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
- (2013) D. T. Wiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pericyte loss influences Alzheimer-like neurodegeneration in mice
- (2013) Abhay P. Sagare et al. Nature Communications
- Neuroprotective effects of donepezil against cholinergic depletion
- (2013) Debora Cutuli et al. Alzheimers Research & Therapy
- Amyloid β-protein oligomers and Alzheimer’s disease
- (2013) Eric Y Hayden et al. Alzheimers Research & Therapy
- Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
- (2012) Kwok Kin Cheng et al. AAPS Journal
- Versatile and Efficient Targeting Using a Single Nanoparticulate Platform: Application to Cancer and Alzheimer’s Disease
- (2012) Benjamin Le Droumaguet et al. ACS Nano
- Deficiency in Mural Vascular Cells Coincides with Blood-Brain Barrier Disruption in Alzheimer's Disease
- (2012) Jesse D. Sengillo et al. BRAIN PATHOLOGY
- Adsorptive-Mediated Brain Delivery Systems
- (2012) Wei Lu CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Nitrile Oxide/Alkyne Cycloadditions - A Credible Platform for Synthesis of Bioinspired Molecules by Metal-Free Molecular Clicking
- (2012) Frances Heaney EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
- (2012) Frédérique Bard et al. EXPERIMENTAL NEUROLOGY
- Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications
- (2012) Letícia Mazzarino et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Aβ Toxicity in Alzheimer's Disease
- (2012) Virve Cavallucci et al. MOLECULAR NEUROBIOLOGY
- Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: Possible applications to Alzheimer disease
- (2012) Adina N. Lazar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
- (2012) Anila Mathew et al. PLoS One
- Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model
- (2012) Weili Jiang et al. PLoS One
- Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings
- (2012) Marcello D’Amelio et al. PROGRESS IN NEUROBIOLOGY
- Terminology for biorelated polymers and applications (IUPAC Recommendations 2012)
- (2012) Michel Vert et al. PURE AND APPLIED CHEMISTRY
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
- (2011) William A. Banks ADVANCED DRUG DELIVERY REVIEWS
- Neuropsychiatric symptoms in Alzheimer’s disease
- (2011) Constantine G. Lyketsos et al. Alzheimers & Dementia
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Curcumin and its nano-formulation: The kinetics of tissue distribution and blood–brain barrier penetration
- (2011) Yin-Meng Tsai et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
- (2011) Sherry L. La Porte et al. JOURNAL OF MOLECULAR BIOLOGY
- Development of Pegylated Liposomal Vincristine Using Novel Sulfobutyl Ether Cyclodextrin Gradient: Is Improved Drug Retention Sufficient to Surpass DSPE–PEG-Induced Drug Leakage?
- (2011) Jingxia Cui et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Biology and pathophysiology of the amyloid precursor protein
- (2011) Hui Zheng et al. Molecular Neurodegeneration
- Central nervous system pericytes in health and disease
- (2011) Ethan A Winkler et al. NATURE NEUROSCIENCE
- Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
- (2011) Rochelle R. Arvizo et al. PLoS One
- Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging
- (2011) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions
- (2010) David W. Klaver et al. BIOLOGICAL CHEMISTRY
- Biphenyl ethers conjugated CdSe/ZnS core/shell quantum dots and interpretation of the mechanism of amyloid fibril disruption
- (2010) Sarika Gupta et al. BIOMATERIALS
- Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
- (2010) Kalpana Nagpal et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
- (2010) Adam Smith et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
- (2010) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)
- (2010) Karsten Ulbrich et al. JOURNAL OF DRUG TARGETING
- The power of thiol-ene chemistry
- (2010) Matthew J. Kade et al. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide
- (2010) Simon Guerrero et al. Nanomedicine
- Pericytes regulate the blood–brain barrier
- (2010) Annika Armulik et al. NATURE
- Pericytes are required for blood–brain barrier integrity during embryogenesis
- (2010) Richard Daneman et al. NATURE
- A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE
- (2010) D. T. Laskowitz et al. NEUROLOGY
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
- (2010) Robert D. Bell et al. NEURON
- In Vivo Methods to Study Uptake of Nanoparticles into the Brain
- (2010) Inge van Rooy et al. PHARMACEUTICAL RESEARCH
- Human absorption of a supplement containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its transient association with low-density lipoproteins
- (2010) Maria González-Santiago et al. PHARMACOLOGICAL RESEARCH
- The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells
- (2010) Richard Daneman et al. PLoS One
- Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
- (2009) Zhao H. Wang et al. BIOMATERIALS
- Characteristics of compounds that cross the blood-brain barrier
- (2009) William A Banks BMC Neurology
- Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain
- (2009) Tapan Parikh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
- (2009) Larry Baum et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Entrapment of Hydrophobic Drugs in Nanoparticle Monolayers with Efficient Release into Cancer Cells
- (2009) Chae Kyu Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine
- (2009) Barnabas Wilson et al. Nanomedicine-Nanotechnology Biology and Medicine
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Thiol-ene “click” reactions and recent applications in polymer and materials synthesis
- (2009) Andrew B. Lowe Polymer Chemistry
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
- (2009) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CNS Delivery Via Adsorptive Transcytosis
- (2008) Françoise Hervé et al. AAPS Journal
- Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
- (2008) Barnabas Wilson et al. BRAIN RESEARCH
- Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles
- (2008) Chunqiang Guo et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
- (2008) B WILSON et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)
- (2008) Karsten Ulbrich et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
- Click Chemistry, A Powerful Tool for Pharmaceutical Sciences
- (2008) Christopher D. Hein et al. PHARMACEUTICAL RESEARCH
- Redox proteomics studies ofin vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress
- (2008) Rukhsana Sultana et al. Proteomics Clinical Applications
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started